β-受体阻滞剂治疗心力衰竭  

Treatment of Heart Failure with β-receptor Blocking Agent

作　　者：石建华[1] 宫亚玲[2] 

机构地区：[1]南开大学医院 [2]淄博市临淄区人民医院

出　　处：《黑龙江医学》2001年第8期569-570,共2页Heilongjiang Medical Journal

摘　　要：目的　观察β -受体阻滞剂治疗心力衰竭的临床疗效。方法　将 60例心力衰竭患者随机分为治疗组和对照组 ,2组均采用强心利尿剂及扩血管剂配合使用 ,治疗组在此基础上 ,加服倍他乐克 (阿斯特拉制药有限公司 ) 2 5～ 50mg ,2次 /d ,心率降至 60～ 70次 /min ,减为 12 .5mg ,2次 /d ;心率在 10 0次 /min以下者予以 6.2 5～ 12 .5mg ,2次 /d ,如无不良反应 ,增至 2 5mg ,2次 /d。结果　治疗组基本治愈 2 6.7% ,显效 4 0 % ,有效 30 % ,无效 3.3% ,总有效率达 96.7% ;对照组基本治愈 13.3% ,显效 16.7% ,有效 4 3.3% ,无效 2 6.7% ,总有效率73.3%。结论　对心力衰竭患者 ,在常规治疗的基础上加用 βObjective To observe the clinical effect of treatment of heart failure with β-receptor blocking agent. Methods 60 cases of heart failure patient were divided into two groups (test group and control group) randomly. All patients were treated with cardiac diuretics and blood vessel dilator and the betaloc was added in test group in dose of 25~50 mg twice a day. When HR decreased at 60~70 times/min the dose of betaloc decreased to 12.5mg and dose of betaloc decreased to 6.25~12.5 when HR decreased at 100 times/min. Results The curative rate was 26.7%, remarked effective rate was 40%, effective rate was 30% and invalid rate was 3.3% in test group (total effective rate was 96.7%). The curative rate was 13.3%, remarked effective rate was 16.7%, effective rate was 43.3% and invalid rate was 26.7% in control group (total effective rate was 73.3%). Conclusion The β-receptor blocking agent based on routine treatment could be safe and effective for heart failure patients

关 键 词：Β-受体阻滞剂 充血性心力衰竭 药物治疗 

分 类 号：R541.61[医药卫生—心血管疾病]